$1.14 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 127 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVT | ROYCE VALUE TR INC | $2,874,000 | +16.6% | 208,900 | 0.0% | 0.25% | -13.4% | |
| AFT | APOLLO SR FLOATING RATE FD I | $1,690,000 | +3.0% | 113,968 | 0.0% | 0.15% | -23.3% | |
| CAF | MORGAN STANLEY CHINA A SH FD | $1,396,000 | +27.8% | 59,800 | 0.0% | 0.12% | -4.7% | |
| KURA | KURA ONCOLOGY INC | $1,332,000 | +18.2% | 80,261 | 0.0% | 0.12% | -12.1% | |
| OPP | RIVERNORTH DOUBLELINE STRATE | $1,053,000 | +1.0% | 64,200 | 0.0% | 0.09% | -25.2% | |
| ERC | WELLS FARGO MULTI SECTOR INC | $857,000 | +9.2% | 70,807 | 0.0% | 0.08% | -18.5% | |
| GER | GOLDMAN SACHS MLP ENERGY REN | $711,000 | +26.1% | 128,507 | 0.0% | 0.06% | -6.1% | |
| NRO | NEUBERGER BERMAN RE ES SEC F | $557,000 | +19.8% | 112,100 | 0.0% | 0.05% | -10.9% | |
| CHI | CALAMOS CONV OPP AND INC FDsh ben int | $239,000 | +14.4% | 23,600 | 0.0% | 0.02% | -16.0% | |
| DNIF | DIVIDEND & INCOME FUND | $214,000 | +19.6% | 18,800 | 0.0% | 0.02% | -9.5% | |
| JRO | NUVEEN FLTNG RTE INCM OPP FD | $152,000 | +6.3% | 15,803 | 0.0% | 0.01% | -23.5% | |
| PIM | PUTNAM MASTER INTER INCOME Tsh ben int | $138,000 | +7.0% | 30,300 | 0.0% | 0.01% | -20.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 37 | Q3 2023 | 5.0% |
| MICROSOFT CORP | 35 | Q3 2023 | 5.5% |
| CITIGROUP INC | 33 | Q2 2021 | 5.8% |
| JPMORGAN CHASE & CO | 33 | Q3 2023 | 3.2% |
| D R HORTON INC | 32 | Q3 2023 | 3.2% |
| TRANSDIGM GROUP INC | 32 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
| JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
| VERACYTE INC | 31 | Q2 2023 | 0.8% |
| LENNAR CORP | 30 | Q1 2022 | 2.7% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
| Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
| Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
| CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
| HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
| Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
| VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
| Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
| MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
| BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.